Terumo (OTCMKTS:TRUMY) Announces Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Terumo (OTCMKTS:TRUMY) announced its quarterly earnings results on Friday. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.17 by $0.13, Zacks reports. Terumo had a net margin of 12.09% and a return on equity of 9.17%.

Terumo Stock Performance

TRUMY stock traded up $1.31 on Friday, hitting $15.85. The company’s stock had a trading volume of 56,969 shares, compared to its average volume of 287,936. The stock has a market cap of $23.38 billion, a price-to-earnings ratio of 25.98 and a beta of 0.68. The firm has a 50 day moving average of $13.98 and a two-hundred day moving average of $13.54. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. Terumo has a 1 year low of $12.08 and a 1 year high of $19.60.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on TRUMY. Zacks Research raised Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.